Methodology shows cost-effectiveness of integrating cervical cancer screening in high HIV burden areas, suggesting improved health outcomes for women.
This methodology article presents a novel framework for conducting a full economic evaluation of integrating cervical cancer screening into existing HIV care programmes in Tanzania's high-burden districts. The urgent need is underscored by the disproportionate cervical cancer burden among women living with HIV in sub-Saharan Africa and the imperative for cost-effective, scalable interventions within constrained health systems. To address this, the proposed methodology employs a pragmatic hybrid design. This combines a prospective micro-costing study (2024-2025) within selected care and treatment clinics to capture real-world resource utilisation with a Markov cohort model to project long-term costs and health outcomes. The model will compare integrated services against a counterfactual of stand-alone care from both health system and societal perspectives, estimating incremental cost-effectiveness ratios (ICERs) in terms of cost per disability-adjusted life year (DALY) averted over a 20-year time horizon. Methodological rigour is strengthened through the use of locally validated epidemiological parameters, the explicit valuation of patient-incurred costs, and a comprehensive probabilistic sensitivity analysis to quantify parameter uncertainty. The framework is designed to generate crucial, context-specific evidence for Tanzanian and regional policymakers, directly informing investment decisions to optimise limited resources and accelerate progress towards the WHO's cervical cancer elimination goals within high HIV prevalence settings.
No takes yet. Share an insight, caveat, or question.
Mwaiselage et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: